RMD
NYSE ResMed Inc.$222.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $222.10, $0.90 below the day’s high of $223.00
- YTD change
- -7.79%
- vs 20-day SMA
- -1.83%
- vs 200-day SMA
- -1.92%
Price ranges
Price & Performance
+2.07 (+0.94%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 26.3% away from all-time highs of $301.34
- RMD is down 8% since the beginning of the year
- RMD is down 18% over the past 12 months
- RMD is down 6% over the past 1 month
- 10% of all RMD investors are betting against RMD
- Number of investors short RMD has gone down 9% versus last month
RMD reads not so good: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -18.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -1.28%
- vs 8-day SMA
- -0.93%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software. The Sleep and Breathing Health segment relates primarily to the sale of therapy-based equipment. The Residential Care Software segment provides software access with ongoing support and maintenance services as well as professional services such as training and consulting. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.